1h Free Analyst Time
The publisher has been monitoring the liposomal products market and is forecast to grow by $3,183.63 mn during 2022-2027, accelerating at a CAGR of 9.65% during the forecast period. Our report on the liposomal products market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of fungal disorders, the growing prevalence of cancer cases, and side effects associated with cancer treatment.
The publisher's liposomal products market is segmented as below:
By Application
- Cancer
- Fungal infections
- Pain management
- Viral vaccines
- Photodynamic therapy
By Type
- Branded
- Generic
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the liposomal products market covers the following areas:
- Liposomal products market sizing
- Liposomal products market forecast
- Liposomal products market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
- Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
- Exhibit 07: Executive Summary - Chart on Incremental Growth
- Exhibit 08: Executive Summary - Data Table on Incremental Growth
- Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- Exhibit 13: Market segments
3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4.1 Global liposomal products market 2017 - 2021
- Exhibit 18: Historic Market Size - Data Table on Global liposomal products market 2017 - 2021 ($ million)
- Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
- Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
- Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
- Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
- Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
- Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
- Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
- Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application
- Exhibit 34: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
- Exhibit 38: Chart on Fungal infections - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Fungal infections - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Fungal infections - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Fungal infections - Year-over-year growth 2022-2027 (%)
- Exhibit 42: Chart on Pain management - Market size and forecast 2022-2027 ($ million)
- Exhibit 43: Data Table on Pain management - Market size and forecast 2022-2027 ($ million)
- Exhibit 44: Chart on Pain management - Year-over-year growth 2022-2027 (%)
- Exhibit 45: Data Table on Pain management - Year-over-year growth 2022-2027 (%)
- Exhibit 46: Chart on Viral vaccines - Market size and forecast 2022-2027 ($ million)
- Exhibit 47: Data Table on Viral vaccines - Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Chart on Viral vaccines - Year-over-year growth 2022-2027 (%)
- Exhibit 49: Data Table on Viral vaccines - Year-over-year growth 2022-2027 (%)
- Exhibit 50: Chart on Photodynamic therapy - Market size and forecast 2022-2027 ($ million)
- Exhibit 51: Data Table on Photodynamic therapy - Market size and forecast 2022-2027 ($ million)
- Exhibit 52: Chart on Photodynamic therapy - Year-over-year growth 2022-2027 (%)
- Exhibit 53: Data Table on Photodynamic therapy - Year-over-year growth 2022-2027 (%)
- Exhibit 54: Market opportunity by Application ($ million)
7.1 Market segments
- Exhibit 55: Chart on Type - Market share 2022-2027 (%)
- Exhibit 56: Data Table on Type - Market share 2022-2027 (%)
- Exhibit 57: Chart on Comparison by Type
- Exhibit 58: Data Table on Comparison by Type
- Exhibit 59: Chart on Branded - Market size and forecast 2022-2027 ($ million)
- Exhibit 60: Data Table on Branded - Market size and forecast 2022-2027 ($ million)
- Exhibit 61: Chart on Branded - Year-over-year growth 2022-2027 (%)
- Exhibit 62: Data Table on Branded - Year-over-year growth 2022-2027 (%)
- Exhibit 63: Chart on Generic - Market size and forecast 2022-2027 ($ million)
- Exhibit 64: Data Table on Generic - Market size and forecast 2022-2027 ($ million)
- Exhibit 65: Chart on Generic - Year-over-year growth 2022-2027 (%)
- Exhibit 66: Data Table on Generic - Year-over-year growth 2022-2027 (%)
- Exhibit 67: Market opportunity by Type ($ million)
8.1 Customer landscape overview
- Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9.1 Geographic segmentation
- Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
- Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
- Exhibit 71: Chart on Geographic comparison
- Exhibit 72: Data Table on Geographic comparison
- Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
- Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
- Exhibit 101: Chart on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 102: Data Table on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 103: Chart on France - Year-over-year growth 2022-2027 (%)
- Exhibit 104: Data Table on France - Year-over-year growth 2022-2027 (%)
- Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 109: Market opportunity By Geographical Landscape ($ million)
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Exhibit 110: Impact of drivers and challenges in 2022 and 2027
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
- Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
- Exhibit 112: Overview on factors of disruption
- Exhibit 113: Impact of key risks on business
12.1 Vendors covered
- Exhibit 114: Vendors covered
- Exhibit 115: Matrix on vendor position and classification
- Exhibit 116: Acthera Therapeutics AG - Overview
- Exhibit 117: Acthera Therapeutics AG - Product/Service
- Exhibit 118: Acthera Therapeutics AG - Key offerings
- Exhibit 119: Bausch Health Companies Inc. - Overview
- Exhibit 120: Bausch Health Companies Inc. - Business segments
- Exhibit 121: Bausch Health Companies Inc. - Key news
- Exhibit 122: Bausch Health Companies Inc. - Key offerings
- Exhibit 123: Bausch Health Companies Inc. - Segment focus
- Exhibit 124: Baxter International Inc. - Overview
- Exhibit 125: Baxter International Inc. - Business segments
- Exhibit 126: Baxter International Inc. - Key news
- Exhibit 127: Baxter International Inc. - Key offerings
- Exhibit 128: Baxter International Inc. - Segment focus
- Exhibit 129: Galen Ltd. - Overview
- Exhibit 130: Galen Ltd. - Product/Service
- Exhibit 131: Galen Ltd. - Key offerings
- Exhibit 132: Gilead Sciences Inc. - Overview
- Exhibit 133: Gilead Sciences Inc. - Product/Service
- Exhibit 134: Gilead Sciences Inc. - Key news
- Exhibit 135: Gilead Sciences Inc. - Key offerings
- Exhibit 136: Innocan Pharma Corp. Ltd. - Overview
- Exhibit 137: Innocan Pharma Corp. Ltd. - Product/Service
- Exhibit 138: Innocan Pharma Corp. Ltd. - Key offerings
- Exhibit 139: Johnson and Johnson Services Inc. - Overview
- Exhibit 140: Johnson and Johnson Services Inc. - Business segments
- Exhibit 141: Johnson and Johnson Services Inc. - Key news
- Exhibit 142: Johnson and Johnson Services Inc. - Key offerings
- Exhibit 143: Johnson and Johnson Services Inc. - Segment focus
- Exhibit 144: Leadiant Biosciences Inc. - Overview
- Exhibit 145: Leadiant Biosciences Inc. - Product/Service
- Exhibit 146: Leadiant Biosciences Inc. - Key offerings
- Exhibit 147: Liposoma B.V. - Overview
- Exhibit 148: Liposoma B.V. - Product/Service
- Exhibit 149: Liposoma B.V. - Key offerings
- Exhibit 150: Merrimack Pharmaceuticals Inc. - Overview
- Exhibit 151: Merrimack Pharmaceuticals Inc. - Product/Service
- Exhibit 152: Merrimack Pharmaceuticals Inc. - Key offerings
- Exhibit 153: Pacira BioSciences Inc. - Overview
- Exhibit 154: Pacira BioSciences Inc. - Business segments
- Exhibit 155: Pacira BioSciences Inc. - Key offerings
- Exhibit 156: Pacira BioSciences Inc. - Segment focus
- Exhibit 157: Spectrum Pharmaceuticals Inc. - Overview
- Exhibit 158: Spectrum Pharmaceuticals Inc. - Product/Service
- Exhibit 159: Spectrum Pharmaceuticals Inc. - Key offerings
- Exhibit 160: Takeda Pharmaceutical Co. Ltd. - Overview
- Exhibit 161: Takeda Pharmaceutical Co. Ltd. - Product/Service
- Exhibit 162: Takeda Pharmaceutical Co. Ltd. - Key news
- Exhibit 163: Takeda Pharmaceutical Co. Ltd. - Key offerings
- Exhibit 164: The Lubrizol Corp. - Overview
- Exhibit 165: The Lubrizol Corp. - Product/Service
- Exhibit 166: The Lubrizol Corp. - Key offerings
- Exhibit 167: Viatris Inc. - Overview
- Exhibit 168: Viatris Inc. - Business segments
- Exhibit 169: Viatris Inc. - Key offerings
- Exhibit 170: Viatris Inc. - Segment focus
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Exhibit 171: Inclusions checklist
- Exhibit 172: Exclusions checklist
- Exhibit 173: Currency conversion rates for US$
- Exhibit 174: Research methodology
- Exhibit 175: Validation techniques employed for market sizing
- Exhibit 176: Information sources
- Exhibit 177: List of abbreviations
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Application
Exhibit 6: Executive Summary - Chart on Market Segmentation by Type
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 18: Historic Market Size - Data Table on Global liposomal products market 2017 - 2021 ($ million)
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
Exhibit 34: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
Exhibit 38: Chart on Fungal infections - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Fungal infections - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Fungal infections - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Fungal infections - Year-over-year growth 2022-2027 (%)
Exhibit 42: Chart on Pain management - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Pain management - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Pain management - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Pain management - Year-over-year growth 2022-2027 (%)
Exhibit 46: Chart on Viral vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Viral vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Viral vaccines - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Viral vaccines - Year-over-year growth 2022-2027 (%)
Exhibit 50: Chart on Photodynamic therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Photodynamic therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Photodynamic therapy - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Photodynamic therapy - Year-over-year growth 2022-2027 (%)
Exhibit 54: Market opportunity by Application ($ million)
Exhibit 55: Chart on Type - Market share 2022-2027 (%)
Exhibit 56: Data Table on Type - Market share 2022-2027 (%)
Exhibit 57: Chart on Comparison by Type
Exhibit 58: Data Table on Comparison by Type
Exhibit 59: Chart on Branded - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Branded - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Branded - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Branded - Year-over-year growth 2022-2027 (%)
Exhibit 63: Chart on Generic - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Generic - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Generic - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Generic - Year-over-year growth 2022-2027 (%)
Exhibit 67: Market opportunity by Type ($ million)
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibit 101: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 109: Market opportunity By Geographical Landscape ($ million)
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
Exhibit 112: Overview on factors of disruption
Exhibit 113: Impact of key risks on business
Exhibit 114: Vendors covered
Exhibit 115: Matrix on vendor position and classification
Exhibit 116: Acthera Therapeutics AG - Overview
Exhibit 117: Acthera Therapeutics AG - Product/Service
Exhibit 118: Acthera Therapeutics AG - Key offerings
Exhibit 119: Bausch Health Companies Inc. - Overview
Exhibit 120: Bausch Health Companies Inc. - Business segments
Exhibit 121: Bausch Health Companies Inc. - Key news
Exhibit 122: Bausch Health Companies Inc. - Key offerings
Exhibit 123: Bausch Health Companies Inc. - Segment focus
Exhibit 124: Baxter International Inc. - Overview
Exhibit 125: Baxter International Inc. - Business segments
Exhibit 126: Baxter International Inc. - Key news
Exhibit 127: Baxter International Inc. - Key offerings
Exhibit 128: Baxter International Inc. - Segment focus
Exhibit 129: Galen Ltd. - Overview
Exhibit 130: Galen Ltd. - Product/Service
Exhibit 131: Galen Ltd. - Key offerings
Exhibit 132: Gilead Sciences Inc. - Overview
Exhibit 133: Gilead Sciences Inc. - Product/Service
Exhibit 134: Gilead Sciences Inc. - Key news
Exhibit 135: Gilead Sciences Inc. - Key offerings
Exhibit 136: Innocan Pharma Corp. Ltd. - Overview
Exhibit 137: Innocan Pharma Corp. Ltd. - Product/Service
Exhibit 138: Innocan Pharma Corp. Ltd. - Key offerings
Exhibit 139: Johnson and Johnson Services Inc. - Overview
Exhibit 140: Johnson and Johnson Services Inc. - Business segments
Exhibit 141: Johnson and Johnson Services Inc. - Key news
Exhibit 142: Johnson and Johnson Services Inc. - Key offerings
Exhibit 143: Johnson and Johnson Services Inc. - Segment focus
Exhibit 144: Leadiant Biosciences Inc. - Overview
Exhibit 145: Leadiant Biosciences Inc. - Product/Service
Exhibit 146: Leadiant Biosciences Inc. - Key offerings
Exhibit 147: Liposoma B.V. - Overview
Exhibit 148: Liposoma B.V. - Product/Service
Exhibit 149: Liposoma B.V. - Key offerings
Exhibit 150: Merrimack Pharmaceuticals Inc. - Overview
Exhibit 151: Merrimack Pharmaceuticals Inc. - Product/Service
Exhibit 152: Merrimack Pharmaceuticals Inc. - Key offerings
Exhibit 153: Pacira BioSciences Inc. - Overview
Exhibit 154: Pacira BioSciences Inc. - Business segments
Exhibit 155: Pacira BioSciences Inc. - Key offerings
Exhibit 156: Pacira BioSciences Inc. - Segment focus
Exhibit 157: Spectrum Pharmaceuticals Inc. - Overview
Exhibit 158: Spectrum Pharmaceuticals Inc. - Product/Service
Exhibit 159: Spectrum Pharmaceuticals Inc. - Key offerings
Exhibit 160: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 161: Takeda Pharmaceutical Co. Ltd. - Product/Service
Exhibit 162: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 163: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibit 164: The Lubrizol Corp. - Overview
Exhibit 165: The Lubrizol Corp. - Product/Service
Exhibit 166: The Lubrizol Corp. - Key offerings
Exhibit 167: Viatris Inc. - Overview
Exhibit 168: Viatris Inc. - Business segments
Exhibit 169: Viatris Inc. - Key offerings
Exhibit 170: Viatris Inc. - Segment focus
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
Exhibit 173: Currency conversion rates for US$
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
Exhibit 177: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global liposomal products market: Acthera Therapeutics AG, Bausch Health Companies Inc., Baxter International Inc., Galen Ltd., GENFIT SA, Gilead Sciences Inc., Innocan Pharma Corp. Ltd., Johnson and Johnson Services Inc., Leadiant Biosciences Inc., Lipella Pharmaceuticals Inc., Liposoma B.V., Merrimack Pharmaceuticals Inc., Nanovex Biotechnologies SL, Pacira BioSciences Inc., Spectrum Pharmaceuticals Inc., Taiwan Liposome Co. Ltd., Takeda Pharmaceutical Co. Ltd., The Lubrizol Corp., Vascular Biosciences, and Viatris Inc.Commenting on the report, an analyst from the researcher said: 'The latest trend gaining momentum in the market is rising adoption of quality by design (QBD) over traditional processes.'
According to the report, one of the major drivers for this market is the rising incidence of fungal disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acthera Therapeutics AG
- Bausch Health Companies Inc.
- Baxter International Inc.
- Galen Ltd.
- GENFIT SA
- Gilead Sciences Inc.
- Innocan Pharma Corp. Ltd.
- Johnson and Johnson Services Inc.
- Leadiant Biosciences Inc.
- Lipella Pharmaceuticals Inc.
- Liposoma B.V.
- Merrimack Pharmaceuticals Inc.
- Nanovex Biotechnologies SL
- Pacira BioSciences Inc.
- Spectrum Pharmaceuticals Inc.
- Taiwan Liposome Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- The Lubrizol Corp.
- Vascular Biosciences
- Viatris Inc.
